Army could well be waiting on results of higher doses (I would have been) so hopefully back in discussion shortly. The dosing was simply far too low in the original trial, but they know a lot more now than they did back then.
This area really gets my interest. Of course Autism and all those potentials are fantastic too, but this is further along having already learnt a lot with the first trial, it could move much more quickly and be a game changer for the company too.
Army could well be waiting on results of higher doses (I would...
-
- There are more pages in this discussion • 12 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$21.27 |
Change
0.650(3.15%) |
Mkt cap ! $2.718B | |||
| Open | High | Low | Value | Volume |
| $20.84 | $21.56 | $20.76 | $7.760M | 364.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 1378 | $21.24 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $21.29 | 218 | 1 |
View Market Depth
| Last trade - 16.10pm 28/06/2024 (20 minute delay) ? |
| NEU (ASX) Chart |